Company profile
KEJAKO SA
Kejako research and develop novel medical devices for the worldwide ophthalmic surgery market. Our technical and commercial goal is to launch premium, innovative solutions for common ophthalmic diseases which have high impact on people's everyday life.
Source: startup.ch
More news about KEJAKO SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
